SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Zealand Pharma Announces That Once-Daily Lyxumia® 1 (lixisenatide) Has Received CHMP Positive Opinion for the Treatment of Adults With Type 2 Diabetes in the EU